ACCURONIX THERAPEUTICS
We are applying a novel drug-targeting technology to some of the most difficult problems in cancer therapy.
ACCURONIX THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Website Url:
http://www.accuronix.com
Total Employee:
1+
Status:
Active
Total Funding:
625 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Euro WordPress 6.0
Current Employees Featured
Founder
Investors List
Missouri Technology Corporation
Missouri Technology Corporation investment in Seed Round - Accuronix Therapeutics
BioGenerator
BioGenerator investment in Seed Round - Accuronix Therapeutics
Official Site Inspections
http://www.accuronix.com
- Host name: 172.67.134.181
- IP address: 172.67.134.181
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Accuronix Therapeutics"
Accuronix Therapeutics - Crunchbase Company Profile โฆ
Accuronix Therapeutics develops drug conjugates targeting the ฯ-2 receptor, overexpressed in most human cancers, for selective delivery of therapeutic โฆSee details»
Our Approach - Accuronix
Company Overview Accuronix Therapeutics is a leader in discovering and developing a new class of drugs that work by selectively targeting the ฯ-2 (sigma-2) receptor on cancer cells to deliver cytotoxic payloads. The Accuronix team โฆSee details»
Accuronix Therapeutics Inc - VentureRadar
Accuronix is pioneering the development of novel cancer therapies that selectively target tumor cells, delivering cytotoxic payloads to increase efficacy and reduce toxicity. Utilizing a unique โฆSee details»
Contact Us - Accuronix
With an initial focus in pancreatic cancer, the Companyโs mission is to develop novel oncology therapies based on technology that selectively targets ฯ-2 receptors overexpressed on cancer โฆSee details»
Accuronix Therapeutics - PitchBook
Accuronix Therapeutics General Information Description. Operator of a clinical-stage biopharmaceutical company intended to develop novel cancer therapies. The company's therapies are based on technology that selectively targets โฆSee details»
Accuronix Therapeutics - Contacts, Employees, Board Members, โฆ
Accuronix Therapeutics is a biotech company that develops drug targeting technology to resolve issues in cancer therapy.See details»
Accuronix Therapeutics | Seed
Accuronix Therapeutics, Inc., is a small pharmaceutical company developing drugs for cancer treatment. The company was originally founded in 2015 by two faculty members at โฆSee details»
Accuronix Therapeutics - Funding, Financials, Valuation & Investors
Accuronix Therapeutics is a biotech company that develops drug targeting technology to resolve issues in cancer therapy. New. Resources. Advanced Search. ... How much funding has this โฆSee details»
Accuronix Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Accuronix Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Neoplasms, Technology Platform:Small molecule-drug โฆSee details»
ACCURONIX THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ACCURONIX THERAPEUTICS, INC. of Saint Louis, MO. Get the latest business insights from Dun & โฆSee details»
Accuronix Therapeutics - Missouri Technology Corporation
Accuronix TherapeuticsSee details»
Accuronix Therapeutics (USA) Funding: $625K
Mar 11, 2025 Accuronix Therapeutics is a biotech company that develops drug targeting technology to resolve issues in cancer therapy. The startupโs lead candidate ACXT-3102, โฆSee details»
Accuronix.com - Overview, News & Competitors - ZoomInfo
Accuronix.com - Business Information Business Services · <25 Employees Accuronix develops novel therapies that selectively target cells and deliver cytotoxic payloads, thereby increasing โฆSee details»
Accuronix Therapeutics - Overview, News & Similar companies
Accuronix's s-2 platform enables the discovery of selective molecularly targeted drug conjugates for a variety of therapeutic cargoes to treat a range of cancers. We are working to advance the โฆSee details»
Founders - Accuronix
William Hawkins, MD Neidorff Family and Robert C. Packman Professor of Surgery Chief, Section of Hepatobiliary, Pancreatic, & Gastrointestinal Surgery Washington University School of โฆSee details»
Accuronix Therapeutics | St. Louis BioTech Startup | EQ
Nov 3, 2016 Accuronix Therapeutics Articles. 6 WashU faculty-founded startups show velocity for university business creation. Tanya Yatzeck November 3, 2016 May 13, 2020 3 Min Read. โฆSee details»
News - Accuronix
Jan 26, 2016 Accuronix was established based on technologies developed at Washington University in St. Louis by Dr. William Hawkins, Professor of Surgery, and his collaborator, Dr. โฆSee details»
BioGenerator Company Accuronix Targets Pancreatic Cancer
Pancreatic Cancer causes 40,000 deaths each year, with available chemotherapy regimens providing only an average of 6-11 months survival. WashU-born company Accuronix, founded โฆSee details»
BioGenerator Leads Investment in Accuronix Therapeutics
Accuronix was established based onโฆ Company developing pharmaceuticals to treat the most difficult cancers BioGenerator, an evergreen investor that creates, grows and invests in โฆSee details»